Malte Peters
Director, Tango Therapeutics (United States).
Companies
- Tango Therapeutics (United States)Chief executive officer Jan 12, 2026 to now1
- HOOKIPA Pharma Inc.Chief executive officer Jul 24, 2024 to now2
- HOOKIPA Pharma Inc.Board member Apr 18, 2023 to now3
- Tango Therapeutics (United States)Board member Aug 12, 2021 to now4
- Tango Therapeutics (United States)President Jan 12, 2026 to Feb 4, 20261
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Tango Therapeutics (United States) TNGX367,500 shares5$8.3M at $22.45Jan 8, 2026
- HOOKIPA Pharma Inc.54,347 shares6Aug 19, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 8, 2026Granted 350,000 shares of Tango Therapeutics (United States)5
- Aug 19, 2025Sold 25,172 shares at $0.82 of HOOKIPA Pharma Inc.6
- Jul 22, 2025Sold 29,176 shares at $0.92 of HOOKIPA Pharma Inc.7
- Jun 5, 2025Granted 6,250 shares of Tango Therapeutics (United States)8
- Jul 22, 2024Granted 108,695 shares of HOOKIPA Pharma Inc.9
- Jun 5, 2024Granted 6,250 shares of Tango Therapeutics (United States)10
- Jun 6, 2023Granted 5,000 shares of Tango Therapeutics (United States)11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARHOOKIPA Pharma Inc., Board member
- 4
- 5
- 6
- 7SEC EDGARForm 4 filed Jul 23, 2025
- 8SEC EDGARForm 4 filed Jun 9, 2025
- 9SEC EDGARForm 4 filed Jul 24, 2024
- 10SEC EDGARForm 4 filed Jun 7, 2024
- 11SEC EDGARForm 4 filed Jun 8, 2023